Observation of Treatment With Certolizumab Pegol in Daily Practice
NCT ID: NCT01069419
Last Updated: 2015-10-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1117 participants
OBSERVATIONAL
2009-10-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis
NCT01590966
Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia
NCT01147341
Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients
NCT01288287
Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)
NCT01374971
Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors
NCT01764321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cimzia
All patients will be treated with Cimzia according to normal clinical practice for the prescribing physician and as defined by the SmPC
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UCB Pharma GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
UCB Clinical Trial Call center
Role: STUDY_DIRECTOR
+1 877 822 9493 (UCB)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
174
Altenburg, , Germany
70
Amberg, , Germany
122
Attendorn, , Germany
153
Augsburg, , Germany
3
Bad Aibling, , Germany
133
Bad Bramstedt, , Germany
167
Bad Buchau, , Germany
20
Bad Doberan, , Germany
166
Bad Endbach, , Germany
8
Bad Iburg, , Germany
66
Bad Kissingen, , Germany
137
Bad Kreuznach, , Germany
119
Bad Liebenwerda, , Germany
4
Bad Nauheim, , Germany
13
Bad Neuenahr-Ahrweiler, , Germany
87
Bad Staffelstein, , Germany
173
Baden-Baden, , Germany
19
Bamberg, , Germany
115
Bautzen, , Germany
21
Bayreuth, , Germany
58
Bayreuth, , Germany
112
Berlin, , Germany
12
Berlin, , Germany
163
Berlin, , Germany
179
Berlin, , Germany
1
Berlin, , Germany
25
Berlin, , Germany
26
Berlin, , Germany
43
Berlin, , Germany
54
Berlin, , Germany
59
Berlin, , Germany
61
Berlin, , Germany
72
Berlin, , Germany
78
Berlin, , Germany
91
Berlin, , Germany
95
Berlin, , Germany
28
Chemnitz, , Germany
75
Chemnitz, , Germany
16
Cologne, , Germany
73
Cologne, , Germany
97
Cologne, , Germany
134
Darmstadt, , Germany
71
Darmstadt, , Germany
125
Deggendorf, , Germany
131
Dresden, , Germany
36
Dresden, , Germany
88
Dresden, , Germany
98
Dresden, , Germany
49
Duisburg, , Germany
46
Düsseldorf, , Germany
102
Elmshorn, , Germany
83
Erfurt, , Germany
2
Erlangen, , Germany
37
Essen, , Germany
84
Essen, , Germany
136
Frankenberg-Sachsen, , Germany
103
Frankfurt, , Germany
53
Frankfurt, , Germany
29
Freiberg, , Germany
86
Freiburg im Breisgau, , Germany
77
Fulda, , Germany
15
Goslar, , Germany
100
Göttingen, , Germany
89
Gräfelfing, , Germany
135
Greifswald, , Germany
107
Güstrow, , Germany
157
Hagen, , Germany
150
Haldensleben I, , Germany
11
Halle, , Germany
116
Hamburg, , Germany
128
Hamburg, , Germany
139
Hamburg, , Germany
175
Hamburg, , Germany
50
Hamburg, , Germany
55
Hamburg, , Germany
67
Hamburg, , Germany
6
Hamburg, , Germany
129
Hanau, , Germany
159
Hanover, , Germany
171
Hanover, , Germany
17
Hanover, , Germany
138
Heidelberg, , Germany
146
Heidelberg, , Germany
47
Heidelberg, , Germany
92
Heilbad Heiligenstadt, , Germany
64
Herrsching am Ammersee, , Germany
5
Hildesheim, , Germany
30
Hofheim, , Germany
48
Hoyerswerda, , Germany
130
Karlsruhe, , Germany
56
Karlsruhe, , Germany
96
Karlsruhe, , Germany
101
Karlstadt am Main, , Germany
121
Kassel, , Germany
161
Katzhütte, , Germany
158
Kiel, , Germany
127
Leipzig, , Germany
51
Ludwigsfelde, , Germany
140
Ludwigslust, , Germany
93
Lübeck, , Germany
68
Magdeburg, , Germany
145
Mainz, , Germany
31
Marktredwitz, , Germany
94
Mittelherwigsdorf, , Germany
18
Mönchengladbach, , Germany
104
Mühlheim An Der Ruhr, , Germany
10
München, , Germany
164
München, , Germany
178
München, , Germany
9
München, , Germany
113
Münster, , Germany
123
Münster, , Germany
57
Naunhof, , Germany
32
Neubrandenburg, , Germany
108
Neuburg am Inn, , Germany
149
Neuruppin, , Germany
44
Neuss, , Germany
7
Nienburg, , Germany
141
Norderstedt, , Germany
172
Nuremberg, , Germany
22
Nuremberg, , Germany
99
Oberammergau, , Germany
23
Oberhausen, , Germany
33
Offenburg, , Germany
38
Osnabrück, , Germany
154
Paderborn, , Germany
34
Pirna, , Germany
81
Planegg, , Germany
85
Plauen, , Germany
27
Potsdam, , Germany
35
Potsdam, , Germany
24
Ratingen, , Germany
82
Rendsburg, , Germany
124
Rheine, , Germany
109
Rostock, , Germany
76
Rostock, , Germany
90
Rüdersdorf, , Germany
39
Saarbrücken, , Germany
69
Salzwedel, , Germany
117
Schramberg-Sulgen, , Germany
143
Schwerin, , Germany
142
Schwerte, , Germany
120
Seesen, , Germany
105
Stadtbergen, , Germany
14
Stuttgart, , Germany
40
Stuttgart, , Germany
160
Traunstein, , Germany
170
Treuenbrietzen, , Germany
41
Tübingen, , Germany
168
Uffenheim, , Germany
111
Ulm, , Germany
65
Ulm, , Germany
52
Villingen-Schwenningen, , Germany
106
Weener, , Germany
162
Weiden, , Germany
177
Weißenfels, , Germany
118
Wiesbaden, , Germany
74
Wiesbaden, , Germany
60
Winsen, , Germany
165
Würselen, , Germany
152
Würzburg, , Germany
110
Zeven, , Germany
45
Zwiesel, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
FDA Safety Alerts and Recalls
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RA0027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.